Korea Securities Finance Corp. (KSF) is preparing to issue its first foreign currency-denominated bonds in 2026 to provide low-cost funding to domes...
May 09, 2025 (Gmt+09:00)
Woori Financial Group Inc., South Korea’s fourth-largest financial services provider, has received conditional approval from the country&rsquo...
May 02, 2025 (Gmt+09:00)
POSCO Future M Co., South Korea’s leading battery materials maker, is set to manufacture spherical graphite – a critical material for ba...
Apr 23, 2025 (Gmt+09:00)
As order books swell amid green shipping mandates, LNG demand and military naval modernization, South Korean shipbuilders are extending their global...
Apr 14, 2025 (Gmt+09:00)
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
South Korea’s National Pension Service (NPS) is projected to nearly double its fund size to 3,500 trillion won ($2.38 trillion) by 2050, follo...
Mar 24, 2025 (Gmt+09:00)
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
Feb 19, 2025 (Gmt+09:00)
New funding to South Korean tech startups dropped to its lowest level in seven years in 2024. But seed funding soared 142% led by semiconductor, hea...
Feb 03, 2025 (Gmt+09:00)
KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...
Jan 10, 2025 (Gmt+09:00)
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
South Korea will raise the limits on forward dollar purchases and expand the foreign exchange swap line between the National Pension Service (NPS) a...
Dec 23, 2024 (Gmt+09:00)
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
South Korea’s commercial vehicle sales are plunging on sluggish domestic demand amid a slowdown in Asia’s fourth-largest economy.Local s...
Dec 12, 2024 (Gmt+09:00)
South Korean companies are postponing bond issues and initial public offerings on chilled investor sentiment in the aftermath of President Yoon Suk ...
Dec 11, 2024 (Gmt+09:00)
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
South Korean President Yoon Suk Yeol survived an impeachment vote against him after an overwhelming majority of governing party lawmakers boycotted ...
Dec 07, 2024 (Gmt+09:00)
Cash holdings at South Korean companies have soared to a record-high level, data showed on Monday. Companies are stepping up efforts to raise cash t...
Dec 02, 2024 (Gmt+09:00)
Rebellions Inc., a South Korean artificial intelligence chip design startup, officially merged with Sapeon Korea to form the first domestic AI chi...
Dec 02, 2024 (Gmt+09:00)